Skip to main content
Equibles

Venrock Adviser, LLC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1615982 NEW YORK, NY
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$25,129,162
+$5,519,860 QoQ
Shares Held
1,379,965
0.0% QoQ
Ownership
2.14%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#13
of 183 holders
Holding Since
Mar 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Venrock Adviser, LLC holds $3,294,790,938 across 31 Biotechnology names. CGEM ranks #22 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 APGE
Apogee Therapeutics, Inc.
 8,493,321 $1,127,318,496
2 ORKA
Oruka Therapeutics, Inc.
 4,148,428 $394,805,892
3 ERAS
Erasca, Inc.
 17,891,812 $327,777,995
4 SYRE
Spyre Therapeutics, Inc.
 2,985,448 $265,048,073
5 DNTH
Dianthus Therapeutics, Inc. /DE/
 1,180,000 $115,026,400
6 OCUL
Ocular Therapeutix, Inc
 10,346,926 $101,606,813
7 DMRA
Damora Therapeutics, Inc.
 3,603,595 $93,729,505
8 SVRA
Savara Inc
 14,745,943 $90,835,008

All Filings in CGEM

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $25,129,162 1,379,965
2026-03-31 $19,609,302 1,379,965
2025-12-31 $14,282,637 1,379,965
2025-09-30 $8,183,192 1,379,965
2025-06-30 $10,391,136 1,379,965
2025-03-31 $10,446,335 1,379,965
2024-12-31 $16,807,973 1,379,965
2024-09-30 $23,100,614 1,379,965
2024-06-30 $24,066,589 1,379,965
2021-09-30 $15,935,548 706,050
2021-06-30 $25,135,733 976,145
2021-03-31 $49,009,962 1,176,145